Skip to content

Hemostatic and Analgesic Effect of Gel Foam and Gauze With Bosmin After Anal Surgery

Hemostatic and Analgesic Effect of Gel Foam and Gauze With Bosmin After Anal Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05605080
Enrollment
292
Registered
2022-11-04
Start date
2022-11-07
Completion date
2023-11-20
Last updated
2023-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemorrhoids, Anal Fistula

Brief summary

To evaluate the hemostatic and analgesic effect of using gauze with Bosmin or Gelfoam after anal surgery.

Detailed description

Hemorrhoidectomy and fistulotomy these two types of anal surgery are common surgeries in colon and rectal surgery division in Shuang Ho hospital. For these patients underwent surgical treatment, some surgeons used gauze with Bosmin for hemostasis and analgesia after surgery, and other surgeons used Gelfoam. These choices were often determined by surgeon's personal preference according to their experiences. Shuang Ho hospital has top three quantity of hemorrhoidectomy in Taiwan. So, a randomized controlled trial is conducted to evaluate the difference between hemostatic agents use after anal surgery.

Interventions

DEVICEGelfoam

Use Gelfoam as a hemostatic agent after anal surgery.

OTHERBosmin gauze

Use bosmin gauze as a hemostatic agent after anal surgery.

Sponsors

Taipei Medical University Shuang Ho Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Patients who undergo conventional hemorrhoidectomy or stapled hemorrhonidpexy are include. * Patients who undergo fistulectomy or fistulotomy are include.

Exclusion criteria

* Emergency operation * Patients with colorectal cancer * Liver cirrhosis * Patients with coagulopathy * Patients with HIV infection

Design outcomes

Primary

MeasureTime frameDescription
Post-operative pain0-7 daysRecord maximum pain score (visual analog scale, 0-10) from post-operative day 0 to day 7.
Analgesic agent use0-7daysDaily consumption of oral analgesics from post-operative day 0 to day 7

Secondary

MeasureTime frameDescription
Incidence of post-operative bleeding0-30 daysPostoperative delayed bleeding was defined as (1) when the bleeding required surgical intervention or (2) when hospital re-admission was warranted after patient discharge.
Incidence of urinary retention0-7 daysUrinary retention was defined as patients requiring Foley catheterization during the hospital stay
Incidence of surgical site infection0-30 daysSurgical site infection was defined as hospital admission for infection management or need for surgical intervention to manage the wound.

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026